Tci Wealth Advisors, Inc. Organon & Co. Transaction History

Tci Wealth Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 03, 2023	SELL	$21.42 - $32.08 $6,704 - $10,041	-313 Reduced 37.67%	518 $12,000
Q4 2022 Feb 06, 2023	BUY	$23.31 - $28.61 $5,804 - $7,123	249 Added 42.78%	831 $23,000
Q3 2022 Nov 08, 2022	SELL	$23.4 - $34.25 $304 - $445	-13 Reduced 2.18%	582 $14,000
Q2 2022 Jul 19, 2022	BUY	$31.66 - $38.9 $2,089 - $2,567	66 Added 12.48%	595 $20,000
Q1 2022 Apr 29, 2022	SELL	$30.45 - $39.36 $2,557 - $3,306	-84 Reduced 13.7%	529 $19,000
Q4 2021 Jan 24, 2022	SELL	$28.67 - $37.13 $4,931 - $6,386	-172 Reduced 21.91%	613 $19,000
Q3 2021 Oct 29, 2021	BUY	$28.63 - $35.64 $2,748 - $3,421	96 Added 13.93%	785 $26,000
Q2 2021 Aug 02, 2021	BUY	$28.45 - $38.0 $19,602 - $26,182	689 New	689 $21,000

813

201M

1.53M

1.07M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.91B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Tci Wealth Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Tci Wealth Advisors, Inc. with notifications on news.